1. Blocking activation site of translation.2. Degraded by an enzyme RNAse
One way to block the activation site is by using molecules called antisense oligonucleotides
1. Blocking activation site of translation: The activation site of translation is the specific region on messenger RNA (mRNA) where the ribosome binds and initiates protein synthesis. By blocking this site, translation of the mRNA can be prevented.
One way to block the activation site is by using molecules called antisense oligonucleotides. These are short sequences of nucleotides that are complementary to the activation site on the mRNA. When the antisense oligonucleotide binds to the activation site, it forms a stable duplex structure, preventing the ribosome from binding and initiating translation.
Another approach to block the activation site is through the use of small interfering RNAs (siRNAs) or microRNAs (miRNAs). These are small RNA molecules that can specifically target and bind to mRNA molecules, leading to their degradation or preventing their translation. This binding can occur at the activation site, effectively blocking translation.
2. Degraded by an enzyme RNAse: RNAse is an enzyme that specifically degrades RNA molecules. It recognizes the RNA molecule and breaks it down into smaller fragments or individual nucleotides. This degradation can occur in various cellular compartments, such as the cytoplasm or within specific organelles like the nucleus or mitochondria.
In the context of translation, RNAse can degrade the mRNA molecules, preventing their translation into proteins. This can happen naturally as part of cellular processes, but RNAse can also be introduced artificially to inhibit translation.
When RNAse activity is increased, either naturally or artificially, it leads to decreased levels of mRNA molecules available for translation, resulting in reduced protein production. This can be achieved by introducing synthetic RNAse molecules or by activating endogenous RNAse enzymes within the cell.
More Answers:
Assessing the Correctness of Scientific Claims: A Comprehensive Guide to Evaluating Evidence and MethodologyUnlocking the Potential: Genetic Engineering and Transgenic Organisms Explained
Advancements in Medication: Vitravene, KYNAMRO, Custirsen, ISIS GCGR, and Alicaforsen